TREA

87724721 - TRANSBIOTICS

Follow

Information

  • Trademark
  • 87724721
  • Serial Number
    87724721
  • Filing Date
    December 18, 2017
    7 years ago
  • Transaction Date
    January 07, 2020
    5 years ago
  • Status Date
    November 25, 2019
    5 years ago
  • Published for Opposition Date
    August 28, 2018
    6 years ago
  • Location Date
    October 23, 2018
    6 years ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    HILLIARD, JESSICA LYNN
  • Attorney Docket Number
    90115.00110
    Attorney Name
    David S. Kerr
    Law Office Assigned Location Code
    N20
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
TRANSBIOTICS
Case File Statements
  • GS0011: Cultures of microorganisms other than for medical and veterinary use, namely, genetically modified microorganisms that express interfering molecules that inhibit the expression of target genes; Cultures of microorganisms other than for medical or veterinary use, namely, genetically modified microorganisms for use in therapeutic treatment of pathogens in plants, namely, microorganisms that express RNA-based therapeutic agents that inhibit the expression of target pathogen genes; Cultures of microorganisms other than for medical or veterinary use, namely, probiotic compositions for use in therapeutic treatment of pathogens in plants, namely, genetically engineered bacteria that express RNA-based therapeutic agents to inhibit the expression of target pathogen genes; Probiotic compositions use as ingredients for food and beverages, namely, genetically engineered probiotic bacteria that express RNA-based therapeutic agents to inhibit the expression of target pathogen genes; Probiotic compositions for use as ingredients for food and beverages, namely, genetically modified probiotic bacteria configured to produce bioavailable nutritional compounds; Cultures of microorganisms for medical or agricultural use, namely, genetically modified endophytic bacteria for use in therapeutic treatment of pathogens in plants
  • GS0051: Cultures of microorganisms for medical and veterinary use, namely, genetically modified microorganisms that express interfering molecules that inhibit the expression of target genes; Biological preparations for the treatment of infectious diseases in animals, namely, biotheraputics consisting of genetically modified microorganisms that express RNA-based therapeutic agents that inhibit the expression of target animal pathogen genes; Biological preparations for the treatment of infectious diseases in plants, namely, biotheraputics consisting of genetically modified microorganisms that express RNA-based therapeutic agents that inhibit the expression of target plant pathogen genes; Biological preparations for the treatment of viral infections in plants, namely, biotheraputics consisting of genetically modified microorganisms that express RNA-based therapeutic agents that inhibit the expression of target viral pathogen genes; Biological preparations for the treatment of bacterial infections in animals, namely, biotheraputics consisting of genetically modified microorganisms that express RNA-based therapeutic agents that inhibit the expression of target bacterial pathogen genes; Biological preparations for the treatment of fungal diseases, namely, biotheraputics consisting of genetically modified microorganisms that express RNA-based therapeutic agents that inhibit the expression of target fungal pathogen genes; Cultures of microorganisms for medical or veterinary use, namely, genetically modified microorganisms for use in therapeutic treatment of pathogens in animals, namely, microorganisms that express RNA-based therapeutic agents that inhibit the expression of target pathogen genes; Probiotic preparations for medical or veterinary use, namely, probiotic compositions for use in therapeutic treatment of pathogens in animals, namely, genetically engineered bacteria that express RNA-based therapeutic agents to inhibit the expression of target pathogen genes; Cultures of microorganisms for medical or veterinary use, namely, genetically modified enteric bacteria for use in therapeutic treatment of pathogens in animals; Medical, biological and pharmaceutical preparations for the prevention and treatment of infectious diseases in plants and animals; biological RNA-based therapeutic agents for the prevention and treatment of infectious diseases in plants and animals; Cultures of microorganisms for medical or veterinary use, namely, biological RNA-based therapeutic agents that inhibit the expression of target genes in plant pests and herbivores
Case File Event Statements
  • 11/25/2019 - 5 years ago
    26 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6
  • 11/25/2019 - 5 years ago
    25 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 10/9/2019 - 5 years ago
    24 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 4/25/2019 - 5 years ago
    23 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 4/23/2019 - 5 years ago
    22 - EXTENSION 1 GRANTED Type: EX1G
  • 4/23/2019 - 5 years ago
    21 - EXTENSION 1 FILED Type: EXT1
  • 4/23/2019 - 5 years ago
    20 - TEAS EXTENSION RECEIVED Type: EEXT
  • 10/23/2018 - 6 years ago
    19 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 8/28/2018 - 6 years ago
    18 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 8/28/2018 - 6 years ago
    17 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/8/2018 - 6 years ago
    16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/23/2018 - 6 years ago
    15 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/23/2018 - 6 years ago
    14 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 7/23/2018 - 6 years ago
    13 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 7/23/2018 - 6 years ago
    12 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 7/23/2018 - 6 years ago
    11 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 7/2/2018 - 6 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/2/2018 - 6 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/28/2018 - 6 years ago
    8 - ASSIGNED TO LIE Type: ALIE
  • 6/15/2018 - 6 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/30/2018 - 6 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/30/2018 - 6 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/30/2018 - 6 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/28/2018 - 6 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/4/2018 - 7 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 12/21/2017 - 7 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP